Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals

Scandinavian Journal of Immunology

Volumn 51, Issue 2, 2000, Pages 195-201

  Dyrhol Riise, Anne Ma ^c   Brantsaeter A B ^a   Dunlop, O ^a   Baklien, K ^a   Skar, A G ^b   Asjo B ^a   Bruun, J N ^a   Rosok B I ^a  

^a Department of Infectious Diseases ^*

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; ZIDOVUDINE;

ADULT; ARTICLE; CELL ACTIVATION; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA VACCINATION; MEMORY CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIREMIA; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; LEUKOCYTES, MONONUCLEAR; REVERSE TRANSCRIPTASE INHIBITORS; T-LYMPHOCYTE SUBSETS; VIREMIA; ZIDOVUDINE;

EID: 0033963148     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00659.x     Document Type: Article

References (42)

1. 1 Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenherg LA. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 1995;95:2061-6.
2. 2 Lane HC, Fauci AS. Immunologic abnormalities in the acquired immunodeficiency syndrome. Annu Rev Immunol 1985;3:477-500.
3. 3 Brinchmann JE, Vartdal F, Thorsby E. T lymphocyte subset changes in human immunodeficiency virus infection. J Acquir Immune Defic Syndr 1989;2:398-403.
4. 4 Lang W, Perkins H, Anderson RE, Royce R, Jewell N, Winkelstein WJ. Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr 1989;2:63-9.
5. 5 Sprent J. In: Marchalonis JJ, ed. The Lymphocyte: Structure and Function. New York: Dekker, 1977;43-112.
6. + cell turnover. Nature 1995;375:194.
7. + cell turnover. Nature 1995;375:193-4.
8. 8 Hammer SM, Squires KE, Hughes MD et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997;337:725-33.
9. 9 Gulick RM, Mellors JW, Havlir D et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997;337:734-9.
10. 10 Larder BA, Kemp SD. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 1989;246:1155-8.
11. 11 Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989;321:1621-5.
12. + T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-16.
13. 13 Pakker NG, Notermans DW, de-Boer RJ et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 1998;4:208-14.
14. 14 Ullum H, Katzenstein T, Aladdin H et al. Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatment. Scand J Immunol 1999;49:539-47.
15. 15 Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1995;44:1-22.
16. 16 Kroon FP, van-Dissel JT, de-Jong JC, van-Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 1994;8:469-76.
17. 17 Staprans SI, Hamilton BL, Follansbee SE et al. Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 1995;182:1727-37.
18. 18 O'Brien WA, Grovit-Ferbas K, Namazi A et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995;86:1082-9.
19. 19 Røsok B, Voltersvik P, Bjerknes R, Axelsson M, Haaheim LR, Åsjö B. Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals. Clin Exp Immunol 1996;104:203-7.
20. 20 Fowke KR, D'Amico R, Chernoff DN et al. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients. AIDS 1997;11:1013-21.
21. 21 Nagata S, Golstein P. The Fas death factor. Science 1995;267: 1449-56.
22. + T cells. J Exp Med 1997;186:1407-18.
23. 23 Funaro A, Spagnoli GC, Ausiello CM et al. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J Immunol 1990;145:2390-6.
24. 24 Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996;173:321-9.
25. 25 Lederman MM, Connick E, Landay A et al. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. J Infect Dis 1998;178:70-9.
26. + naive T cells following triple-drug therapy for HIV type 1 infection. AIDS Res Hum Retrovir 1999;15:435-43.
27. 27 Dyrhol-Riise AM, Voltersvik P, Røsok BI, Olofsson J, Åsjö B. Normalisation of CD4 cell numbers and reduced levels of memory CD8 cells in blood and tonsillar tissue following HAART in early HIV-1 infection. AIDS Res Hum Retrovir, in press.
28. 28 Silvestri G, Munoz C, Butini L, Bagnarelli P, Montroni M. Changes in CD8 cell subpopulations induced by antiretroviral therapy in human immunodeficiency virus infected patients. Viral Immunol 1997;10:207-12.
29. + T-cells in lymphoid tissues of HIV-1-infected individuals in the absence of the high-affinity IL-2 receptor. J. Acquir Immune Defic Syndr Hum Retrovirol 1998;19:332-8.
30. +) T cells. Proc Natl Acad Sci USA 1997;94:9332-6.
31. 31 Wong JK, Gunthard HF, Havlir DV et al. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci USA 1997;94:12574-9.
32. + lymphocyte population in the blood of SIV-infected macaques is not reflected in lymph nodes. AIDS Res Hum Retrovir 1993;9:639-46.
33. 33 Røsok BI, Bostad L, Voltersvik P et al. Reduced CD4 cell counts in blood do not reflect CD4 cell depletion in tonsillar tissue in asymptomatic HIV-1 infection. AIDS 1996;10:F35-8.
34. + T cells normalises and correlates with the level of infectous provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection. AIDS 1999;13:2365-76.
35. +CD28-T cell subsets in HIV type 1-infected individuals. Eur J Immunol 1998;28:1738-42.
36. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995;332:143-9.
37. 37 Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
38. 38 Wei X, Ghosh SK, Taylor ME et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
39. + T cell turnover. Science 1996;274:1543-7.
40. 40 Fuller JD, Craven DE, Steger KA, Cox N, Heeren TC, Chernoff D. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis 1999;28:541-7.
41. 41 Sabbaj S, Para MF, Fass RJ, Adams PW, Orosz CG, Whitacre CC. Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis. J Clin Immunol 1992;12:216-24.
42. 42 Tite JP, Russell SM, Dougan G et al. Antiviral immunity induced by recombinant nucleoprotein of influenza A virus. I. Characteristics and cross-reactivity of T cell responses. J Immunol 1988;141:3980-7.